Eli Lilly and Boehringer Ingelheim will undercut Sanofi by 15% with Basaglar, a biosimilar version of the insulin blockbuster Lantus launched today in the US. Basaglar will also undercut Sanofi ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo ... and no more than $55 for a box of five pen cartridges – which Civica says is "a significant ...

The top of executive of Novo Nordisk told a Senate panel Tuesday it was a "difficult choice" to discontinue the long-acting ...

At the plant, Civica receives large batches of unfinished drugs and fills vials, syringes and insulin cartridges ... commonly sold under the brand name Lantus. Earlier this month, Civica announced ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...